Cargando…
Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
BACKGROUND: Previous studies have documented a high incidence of toxicity in patients with ultra‐central non‐small cell lung cancer (UC‐NSCLC) treated with stereotactic body radiation therapy (SBRT). However, these studies mainly focused on early stage patients and included small sample populations....
Autores principales: | Cong, Yang, Sun, Bing, Wang, Junliang, Meng, Xiangying, Xuan, Liang, Zhang, Junjian, Liu, Jiannan, Shen, Ge, Wu, Shikai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610283/ https://www.ncbi.nlm.nih.gov/pubmed/31187604 http://dx.doi.org/10.1111/1759-7714.13105 |
Ejemplares similares
-
Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer
por: Meng, Mao‐Bin, et al.
Publicado: (2019) -
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
por: Milano, Michael T, et al.
Publicado: (2008) -
Stereotactic body radiation therapy for centrally-located lung tumors
por: SHEN, GE, et al.
Publicado: (2014) -
Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
por: Cooke, Rosie, et al.
Publicado: (2020) -
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
por: Salvestrini, Viola, et al.
Publicado: (2022)